Intel-GE partnership expands UMMC relationship for operationalizing innovation

Intel-GE Care Innovations, a joint venture between Intel Corporation and GE Healthcare, has expanded its relationship with the Center for Telehealth at the University of Mississippi Medical Center to establish an Innovation Living Lab that will create and evaluate new models of care using remote care management technology and approaches to patient behavior change that will facilitate improvements in health outcomes.

UMMC previously announced plans for the Center for Telehealth to move to the new Venyu Technology Center in 2016 where this Innovation Living Lab will be housed. The goal of the Lab is to build a series of Innovation Projects and operationalize those that most effectively connect the care continuum to the home, beyond the walls of a hospital.

Care Innovations’ expanded work with UMMC also aims to develop a Training and Education Center for care providers including formal caregivers, family caregivers and other staff. The center will have both a physical location and a virtual hub for distance learning and remote access.

“In the traditional healthcare setting, the patient’s condition and activity in the home is rarely accessible to clinicians,” said Kristi Henderson, DNP, UMMC's chief telehealth and innovation officer. “What we’re trying to do here is explore various approaches and locations for care delivery, and a key piece of that is extending care into the home. Our work with Care Innovations has already demonstrated the value of care and data collection in the home, and we’re excited to build upon our successes.” 

Care Innovations already has been working with UMMC on a population health model–-the Diabetes Telehealth Network-–which leverages telehealth technology delivered over high-speed mobile broadband connections and is designed to improve the health of participants while also reducing the total cost of care. 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.